{"id":"https://genegraph.clinicalgenome.org/r/548dbade-ea39-432a-ace1-3c76ae5945f5v1.0","type":"EvidenceStrengthAssertion","dc:description":"GALNT2 was first reported in relation to autosomal receive congenital disorder of glycosylation, type IIt in 2012 ( Holleboom A, et al., 2012, PMID: 22152306). Congenital disorder of glycosylation, type IIt is a multisystemic metabolic disorder characterized by global developmental delay, poor overall growth, severely impaired intellectual development with absent language, and behavioral abnormalities. Most patients develop early-onset seizures. This gene encodes a member of the glycosyltransferase 2 protein family. Members of this family initiate mucin-type O-glycoslation of peptides in the Golgi apparatus. (O'Leary NA et al., 2016, PMID: 26553804) \n\nFour variants (1 missense, 3 nonsense) that have been reported in approximately 4 probands in 1 publications (Zilmer M, et al., 2020, PMID: 32293671), are included in this curation. The mechanism of disease for Immunodeficiency 23 is gene mutations result in the production of an enzyme with reduced activity.  \n\nThis gene-disease relationship is also supported by experimental evidence including expression of enzymatic activity in mouse models (Greig KT, et al., 2007, PMID: 17548465).  In summary, there is strong evidence to support this gene-disease relationship. While more evidence is needed to establish this relationship definitively, no convincing contradictory evidence has emerged. This classification was approved by the ClinGen Congenital Disorder of Glycosylation Expert Panel on the meeting date 9/20/2023 (SOP Version 9). \n\n \n\n ","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/548dbade-ea39-432a-ace1-3c76ae5945f5","GCISnapshot":"https://genegraph.clinicalgenome.org/r/8107f647-e731-44f5-ba38-46e648febab1","calculatedEvidenceStrength":"Strong","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/8107f647-e731-44f5-ba38-46e648febab1_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10135","date":"2024-02-06T20:05:58.337Z","role":"Publisher"},{"id":"https://genegraph.clinicalgenome.org/r/8107f647-e731-44f5-ba38-46e648febab1_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10135","date":"2024-02-06T17:00:00.000Z","role":"Approver"}],"curationReasons":["NewCuration"],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8107f647-e731-44f5-ba38-46e648febab1_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/92b7660b-c292-444a-8d8d-e6948e391777_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1478733a-e565-4c1a-a27a-64a861da30f3","type":"EvidenceLine","calculatedScore":4,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1478733a-e565-4c1a-a27a-64a861da30f3_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Novel congenital disorder of glycosylation, GALNT2-CDG, in which biallelic loss-of-function mutations in the glycosyltransferase isoenzyme gene GALNT2 cause severe multisystem dysfunction.\n","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/1478733a-e565-4c1a-a27a-64a861da30f3_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32293671","allele":{"id":"https://genegraph.clinicalgenome.org/r/33ba8bb9-e729-432d-8ac8-454e14c312bb","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_004481.5(GALNT2):c.598C>T (p.Arg200Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA345181793"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":4},{"id":"https://genegraph.clinicalgenome.org/r/92b7660b-c292-444a-8d8d-e6948e391777","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32293671","rdfs:label":"Patient C","ageType":"AgeAtReport","ageUnit":"Years","ageValue":4,"allele":{"id":"https://genegraph.clinicalgenome.org/r/33ba8bb9-e729-432d-8ac8-454e14c312bb"},"ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"Sanger sequencing","phenotypes":["obo:HP_0011800","obo:HP_0000729","obo:HP_0002194","obo:HP_0000463","obo:HP_0000708","obo:HP_0500041","obo:HP_0001250","obo:HP_0007733","obo:HP_0005280","obo:HP_0000494","obo:HP_0008513","obo:HP_0025325","obo:HP_0000316","obo:HP_0002714","obo:HP_0001249","obo:HP_0005338"],"previousTesting":false,"sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/1478733a-e565-4c1a-a27a-64a861da30f3_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":3},{"id":"https://genegraph.clinicalgenome.org/r/6a273064-5bc6-44e7-afbe-ba2d59b79424_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/48a6d0af-ccd1-42d3-832d-7ccd0718e8a9","type":"EvidenceLine","calculatedScore":4,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/48a6d0af-ccd1-42d3-832d-7ccd0718e8a9_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Plasma apoC-III for probands and family controls of the GALNT2 loss-of-function mutation.","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/48a6d0af-ccd1-42d3-832d-7ccd0718e8a9_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32293671","allele":{"id":"https://genegraph.clinicalgenome.org/r/6c5eb074-8504-4c59-9d05-f00da56c8f65","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_004481.5(GALNT2):c.865C>T (p.Gln289Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA345184941"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":4},{"id":"https://genegraph.clinicalgenome.org/r/6a273064-5bc6-44e7-afbe-ba2d59b79424","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32293671","rdfs:label":"Patient A","ageType":"AgeAtReport","ageUnit":"Years","ageValue":10,"allele":{"id":"https://genegraph.clinicalgenome.org/r/6c5eb074-8504-4c59-9d05-f00da56c8f65"},"ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0000729","obo:HP_0002194","obo:HP_0000494","obo:HP_0031717","obo:HP_0011822","obo:HP_0001572","obo:HP_0000687","obo:HP_0001250","obo:HP_0000708","obo:HP_0001249"],"previousTesting":false,"secondTestingMethod":"Sanger sequencing","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/48a6d0af-ccd1-42d3-832d-7ccd0718e8a9_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":3},{"id":"https://genegraph.clinicalgenome.org/r/fe155a48-8f0e-49d5-8bb8-d8f0eddc892b_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/63cdef0d-47b6-4ac8-9514-adab9f8c9d03","type":"EvidenceLine","calculatedScore":4,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/63cdef0d-47b6-4ac8-9514-adab9f8c9d03_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Novel congenital disorder of glycosylation, GALNT2-CDG, in which biallelic loss-of-function mutations in the glycosyltransferase isoenzyme gene GALNT2 cause severe multisystem dysfunction.\n","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/63cdef0d-47b6-4ac8-9514-adab9f8c9d03_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32293671","allele":{"id":"https://genegraph.clinicalgenome.org/r/e8cb299b-bd53-4e99-81ea-8ad847b05b05","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_004481.5(GALNT2):c.296dup (p.Tyr99Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA1139656626"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":4},{"id":"https://genegraph.clinicalgenome.org/r/fe155a48-8f0e-49d5-8bb8-d8f0eddc892b","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32293671","rdfs:label":"Patient D","ageType":"AgeAtReport","ageUnit":"Years","ageValue":20,"allele":{"id":"https://genegraph.clinicalgenome.org/r/e8cb299b-bd53-4e99-81ea-8ad847b05b05"},"ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"Sanger sequencing","phenotypes":["obo:HP_0002553","obo:HP_0002194","obo:HP_0100785","obo:HP_0001250","obo:HP_0000426","obo:HP_0000708","obo:HP_0500041","obo:HP_0008513","obo:HP_0001249","obo:HP_0000729"],"previousTesting":false,"sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/63cdef0d-47b6-4ac8-9514-adab9f8c9d03_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":3},{"id":"https://genegraph.clinicalgenome.org/r/ff042fe3-d47d-46fc-beca-950af457d2d2_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/61f67bca-43ae-4913-a623-175c07733f0a","type":"EvidenceLine","calculatedScore":1.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/61f67bca-43ae-4913-a623-175c07733f0a_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Novel congenital disorder of glycosylation, GALNT2-CDG, in which biallelic loss-of-function mutations in the glycosyltransferase isoenzyme gene GALNT2 cause severe multisystem dysfunction.\n","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/61f67bca-43ae-4913-a623-175c07733f0a_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32293671","allele":{"id":"https://genegraph.clinicalgenome.org/r/e8e6b62e-6688-4f17-9232-2d8255fb93b2","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_004481.5(GALNT2):c.629G>C (p.Arg210Pro)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA345183300"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/ff042fe3-d47d-46fc-beca-950af457d2d2","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32293671","rdfs:label":"Patient F","ageType":"AgeAtReport","ageUnit":"Years","ageValue":13,"allele":{"id":"https://genegraph.clinicalgenome.org/r/e8e6b62e-6688-4f17-9232-2d8255fb93b2"},"ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"Sanger sequencing","phenotypes":["obo:HP_0000729","obo:HP_0001249","obo:HP_0001572","obo:HP_0011822","obo:HP_0000154","obo:HP_0000445","obo:HP_0100785","obo:HP_0000687","obo:HP_0000639","obo:HP_0000708"],"previousTesting":false,"sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/61f67bca-43ae-4913-a623-175c07733f0a_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/8107f647-e731-44f5-ba38-46e648febab1_seg_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/40230987-64d9-4eb9-a8fd-f1a39b597a0f_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32293671","rdfs:label":"Family 4","estimatedLodScore":0.85,"family":{"id":"https://genegraph.clinicalgenome.org/r/40230987-64d9-4eb9-a8fd-f1a39b597a0f","type":"Family","rdfs:label":"Family 4","ethnicity":{"id":"cg:NotHispanicOrLatino"},"member":{"id":"https://genegraph.clinicalgenome.org/r/ff042fe3-d47d-46fc-beca-950af457d2d2"}},"meetsInclusionCriteria":false,"phenotypeNegativeAlleleNegative":2,"phenotypePositiveAllelePositive":2,"proband":{"id":"https://genegraph.clinicalgenome.org/r/ff042fe3-d47d-46fc-beca-950af457d2d2"}},{"id":"https://genegraph.clinicalgenome.org/r/c9dd244c-283e-43ed-9fc9-c71c1d14c06b_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32293671","rdfs:label":"Family 3","estimatedLodScore":0.85,"family":{"id":"https://genegraph.clinicalgenome.org/r/c9dd244c-283e-43ed-9fc9-c71c1d14c06b","type":"Family","rdfs:label":"Family 3","ethnicity":{"id":"cg:NotHispanicOrLatino"},"member":{"id":"https://genegraph.clinicalgenome.org/r/fe155a48-8f0e-49d5-8bb8-d8f0eddc892b"}},"meetsInclusionCriteria":false,"phenotypeNegativeAlleleNegative":2,"phenotypePositiveAllelePositive":2,"proband":{"id":"https://genegraph.clinicalgenome.org/r/fe155a48-8f0e-49d5-8bb8-d8f0eddc892b"}},{"id":"https://genegraph.clinicalgenome.org/r/d2427894-62f3-44a5-8c10-b81a4733ae01_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32293671","rdfs:label":"Family 1 ","estimatedLodScore":0.98,"family":{"id":"https://genegraph.clinicalgenome.org/r/d2427894-62f3-44a5-8c10-b81a4733ae01","type":"Family","rdfs:label":"Family 1 ","ethnicity":{"id":"cg:NotHispanicOrLatino"},"member":{"id":"https://genegraph.clinicalgenome.org/r/6a273064-5bc6-44e7-afbe-ba2d59b79424"}},"meetsInclusionCriteria":false,"phenotypeNegativeAlleleNegative":3,"phenotypePositiveAllelePositive":2,"proband":{"id":"https://genegraph.clinicalgenome.org/r/6a273064-5bc6-44e7-afbe-ba2d59b79424"}},{"id":"https://genegraph.clinicalgenome.org/r/95eda615-d8fe-47f6-a3fe-5a2bf27bc2e7_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32293671","rdfs:label":"Family 2","estimatedLodScore":0.25,"family":{"id":"https://genegraph.clinicalgenome.org/r/95eda615-d8fe-47f6-a3fe-5a2bf27bc2e7","type":"Family","rdfs:label":"Family 2","ethnicity":{"id":"cg:NotHispanicOrLatino"},"member":{"id":"https://genegraph.clinicalgenome.org/r/92b7660b-c292-444a-8d8d-e6948e391777"}},"meetsInclusionCriteria":false,"phenotypeNegativeAlleleNegative":2,"phenotypePositiveAllelePositive":1,"proband":{"id":"https://genegraph.clinicalgenome.org/r/92b7660b-c292-444a-8d8d-e6948e391777"}}],"specifiedBy":"GeneValiditySegregationEvidenceCriteria","strengthScore":0}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":10},{"id":"https://genegraph.clinicalgenome.org/r/8107f647-e731-44f5-ba38-46e648febab1_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8107f647-e731-44f5-ba38-46e648febab1_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7b370a40-8f43-44da-960b-9da3a97817e4","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b53fa806-c9c0-4ddd-b908-9b0acea59f08","type":"Finding","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27508872","rdfs:label":"GALNT2 deficiency reduced plasma PLTP activity in humans and","demonstrates":{"id":"cg:PhenotypeRescue"}}],"specifiedBy":"GeneValidityNonHumanRescueCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/8107f647-e731-44f5-ba38-46e648febab1_functional_alteration_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/15882c5d-4fb6-425f-9c2e-9103c4d6a525","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e13f1a28-49ea-4570-bca8-cfea50871b22","type":"FunctionalAlteration","dc:description":"ppGalNAc-T2 can affect plasma lipids through posttranslational modification of apoC-III. ","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22152306","rdfs:label":"p.D314A mutation in ppGalNAc-T2"}],"specifiedBy":"GeneValidityNonPatientCellFunctionalAlterationCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalAlterationEvidenceCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/8107f647-e731-44f5-ba38-46e648febab1_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/65a28476-227f-4a27-9f5c-f5194ffab157","type":"EvidenceLine","dc:description":"Expression in many tissues associated with genotypic-phenotypic relationship","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e62b5887-a1c9-4e19-9488-c978183b80c5","type":"Finding","dc:description":"Regulation of glycosylation caused by GALNT2 gene, is defined with patients presented with many human metabolic abnormalities, HDL-C ","dc:source":"https://pubmed.ncbi.nlm.nih.gov/35055114","rdfs:label":"Encoding GALNT2","demonstrates":{"id":"cg:BiochemicalFunctionB"}}],"specifiedBy":"GeneValidityBiochemicalFunctionCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":3.5}],"evidenceStrength":"Strong","sequence":7771,"specifiedBy":"GeneValidityCriteria10","strengthScore":13.5,"subject":{"id":"https://genegraph.clinicalgenome.org/r/bT42Mxu6hSg","type":"GeneValidityProposition","disease":"obo:MONDO_0030043","gene":"hgnc:4124","modeOfInheritance":"obo:HP_0000007"},"version":"1.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_8107f647-e731-44f5-ba38-46e648febab1-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}